ResearchMoz

Coronary Stents Market in India 2013

Netscribes (India) Pvt. Ltd.
Published Date » 2013-10-31
No. Of Pages » 134
   
 Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the...
Table of Content

Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13), Inflation Rate: Monthly (Nov 2012 – Apr 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011-Feb 2012), Exchange Rate: Monthly (Dec 2012 – May 2013)
Slide 4: Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13), Trade Balance: Annual, FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5: Coronary stents – Uses, Characteristics and Types
Slide 6: Development of Coronary Stents

Market Overview
Slide 7: Angioplasties – Overview and Number of Procedures Performed in India (2009 – 2017e)
Slide 8: Coronary Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e)
Slide 9: Drug-Eluting Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e)
Slide 10: Bare Metal Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e)
Slide 11: Bioabsorbable Stents – Market Overview, Market Size & Growth (Value-Wise; 2013e – 2017e & Volume-Wise; 2013e – 2017e)
Slide 12: Coronary Stents – Price Trends

Drivers & Challenges
Slide 13: Drivers and Challenges – Summary
Slide 14-18: Drivers
Slide 19-20: Challenges

Government Involvement
Slide 21: Organizational Structure of Regulatory Bodies
Slide 22-23: Regulatory Bodies
Slide 24-27: Regulatory Policies
Slide 28: Process of Obtaining License for Manufacturing Medical Device Regulated as Drugs in India
Slide 29-31: Requirements for Grant of License for Manufacture of Medical Devices in India
Slide 32: Process of Obtaining Registration for Import of Medical Device Regulated as Drugs in India
Slide 33-37: Documents Required for the Registering Medical Devices for Import into India

Competitive Landscape
Slide 38-40: Entry Barriers
Slide 41: Porter’s Five Forces Analysis
Slide 42: Competition Overview, Market Share of Companies (Volume-Wise; 2012)
Slide 43: Sale of Coronary Stents by Various Companies (2012)
Slide 44-47: Competitive Benchmarking 
Slide 48-96: Major Companies

Buyer Details
Slide 97: List of Top 10 Hospitals Buying Coronary Stents in India
Slide 98-127: Major Buyers
Slide 128: Other Major Purchasers of Stents

Recent Developments
Slide 129: Major Recent Developments in the Market

Strategic Recommendation
Slide 130-131: Key Recommendations
Slide 132: Opportunities by Geography

Appendix
Slide 133: Appendix
Slide 134: Sources of Information

List of Tables


Market Overview
1. Coronary Stents – Price Trends

Government Involvement
1. Reimbursement Rates Under Central Government Health Scheme (2007, 2011, 2013)

Competitive Landscape
1. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Shareholders of the Company (Private Companies, Except B. Braun Medical (India) Pvt. Ltd. & MIV Therapeutics (India) Pvt. Ltd.)
a. Key Financial Performance Indicators (Public Companies)
b. Key Ratios (Except Boston Scientific India Pvt. Ltd.)
e. Business Highlights (All Companies)

Buyer Details
1. Top 10 Hospitals Buying Coronary Stents In India
2. Buyer Profiles (All Companies)
c. Company Information (All Companies)
d. Products and Services (All Companies)
e. Key People (All Companies)
f. Business Highlights (All Companies)
g. Key Hospital Indicators
f. Stent Procurement Procedure

Appendix
2. Appendix
3. Sources of Information

List of Figures


Macro Economic Indicators
1. GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13)
2. Inflation Rate: Monthly (Nov-Dec 2012 – Mar-Apr 2013)
3. Gross Fiscal Deficit: Monthly (Sep 2011 - Feb 2012)
4. Exchange Rate: Monthly (Dec 2012 – May 2013)
5. Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13)
6. Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13)
7. FDI Annual (2009-10, 2010-11, 2011-12, 2012-13)

Market Overview
1. Number of Angioplasty Procedures (2009 – 2017e)
2. Coronary Stents – Market Size & Growth (Value-Wise; 2011 – 2017e)
3. Coronary Stents – Market Size & Growth (Volume-Wise; 2011 – 2017e)
4. Drug-Eluting Stents – Market Size & Growth (Value-Wise; 2011 – 2017e)
5. Drug-Eluting Stents – Market Size & Growth (Volume-Wise; 2011 – 2017e)
6. Bare Metal Stents – Market Size & Growth (Value-Wise; 2011 – 2017e)
7. Bare Metal Stents – Market Size & Growth (Volume-Wise; 2011 – 2017e)
8. Bioabsorbable Stents – Market Size & Growth (Value-Wise; 2013e – 2017e)
9. Bioabsorbable Stents – Market Size & Growth (Volume-Wise; 2013e – 2017e)

Drivers & Challenges
1. CVD Prevalence – Number of Patients (2011 – 2017e)
2. Diabetes Prevalence – Number of Patients (2011 – 2017e)
3. Budget Allocation of Funds for Healthcare Sector (2010-11 – 2013-14)
4. Private Hospitals Market in India (Value-Wise; 2011 – 2017e)
5. Population Above 60 Years (2011 – 2017e)
6. Average Life Expectancy (1960, 1970, 1980, 1990, 2000, 2011)
7. Household Expenditure – Share of Wallet % (2005, 2015e, 2025e)

Competitive Landscape
1. Market Share (Volume-Wise; 2012)
2. Competitive Benchmarking – Key Ratios of 4 Major Companies – Operational & Financial Basis (2011-2012)
3. Company profiles (All Companies)
a. Ownership Structure (Private Companies)
b. Financial Snapshot (Except Boston Scientific India Pvt. Ltd.) 
c. Key Business segments (Public Companies)
d. Key Geographic segments (Public Companies)

Upcoming Reports:

Infectious Diseases In Vitro Diagnostics (IVD) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
By - Transparency Market Research
In vitro diagnostics are the vital tools in health care systems as they provide crucial information for making right medical decisions. The information revealed through these technologies helps physicians in successful management of medical conditions in every stage. Prevalence of infectious diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), Herpes Simplex Virus (HSV), tuberculosis, measles, dengue, Chagas, cholera, and malaria is increasing across the globe with high prevalence in developing countries. There have been...
Cellulosic Ethanol Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Cellulosic ethanol which is manufactured using inedible parts of plants, wood and grasses is a biofuel. Lignocellulose basically is a structural material that consists of mass of plants such as hemicelluloses, cellulose and lignin. Wood chips, panicum virgatum and some byproducts of tree maintenance are various cellulosic materials used for production of ethanol. Ethanol production form lignocellulose has advantage of abundant raw materials than other sources which include cane sugars and corn. These sources require large amount of processing to provide the microorganisms with...
Prokaryotic Expression Systems Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Expression systems are used for the production of large number of biological products such as proteins, enzymes, amino acids, biopolymers from recombinant DNA molecules. The process involves introduction of a foreign DNA into the host cell. The first step involved in various biomolecule production using expression systems is identifying and isolating the DNA to be introduced into the host. This is followed by vector identification and construction of recombinant vector.  An expression vector or plasmid which is responsible for protein expression in cell possess various components such...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...